Literature DB >> 9144547

RNase H activity of human hepatitis B virus polymerase expressed in Escherichia coli.

Y I Lee1, Y B Hong, Y Kim, H M Rho, G Jung.   

Abstract

Human Hepatitis B Virus (HBV) replication is accomplished by its own polymerase. The HBV RNase H domain of HBV polymerase has been expressed in Escherichia coli and purified by affinity column chromatography. The MBP-RNase H fusion protein (43 kDa MBP plus 17 kDa HBV RNase H domain) was proved to be RNase H by in vitro activity assay, inhibitor studies, and mutagenesis. The HBV RNase H domain represented the optimal RNase H activity in the presence of either 8 mM MgCl2 or 16 mM MnCl2. In Tris-Cl buffer, the optimum pH for MBP-RNase H fusion protein is between 7.7 and 8.2. The MBP-RNase H fusion protein required 40 mM monovalent cation for its enzyme activity, whereas it showed lower activity at a salt concentration of more than 100 mM. Ribonucleoside Vanadyl complex (RAV) and 2'-deoxyadenosine 5'-monophosphate (dAMP) inhibited the RNase H activity. Moreover, the mutation of highly conserved amino acids in the HBV RNase H domain diminished the RNase H activity. These results clearly suggest that the RNase H activity is separable from viral HBV polymerase enzymatic activities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144547     DOI: 10.1006/bbrc.1997.6467

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Expression of RNase H of human hepatitis B virus polymerase in Escherichia coli.

Authors:  Hong Cheng; Hui-Zhong Zhang; Wan-An Shen; Yan-Fang Liu; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

2.  The vanadyl ribonucleoside complex inhibits ribosomal subunit formation in Staphylococcus aureus.

Authors:  Ashley D Frazier; W Scott Champney
Journal:  J Antimicrob Chemother       Date:  2012-05-29       Impact factor: 5.790

3.  Active human hepatitis B viral polymerase expressed in rabbit reticulocyte lysate system.

Authors:  Y Kim; G Jung
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

4.  Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.

Authors:  Juan Antonio Villa; Daniel P Pike; Kunjan B Patel; Elena Lomonosova; Gaofeng Lu; Roz Abdulqader; John E Tavis
Journal:  Antiviral Res       Date:  2016-06-17       Impact factor: 5.970

Review 5.  The hepatitis B virus ribonuclease H as a drug target.

Authors:  John E Tavis; Elena Lomonosova
Journal:  Antiviral Res       Date:  2015-04-08       Impact factor: 5.970

6.  Phosphodiester cleavage in ribonuclease H occurs via an associative two-metal-aided catalytic mechanism.

Authors:  Marco De Vivo; Matteo Dal Peraro; Michael L Klein
Journal:  J Am Chem Soc       Date:  2008-07-29       Impact factor: 15.419

7.  Evidence that the RNAseH activity of the duck hepatitis B virus is unable to act on exogenous substrates.

Authors:  Y Gong; E Yao; J E Tavis
Journal:  BMC Microbiol       Date:  2001-07-19       Impact factor: 3.605

8.  The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.

Authors:  John E Tavis; Xiaohong Cheng; Yuan Hu; Michael Totten; Feng Cao; Eleftherios Michailidis; Rajeev Aurora; Marvin J Meyers; E Jon Jacobsen; Michael A Parniak; Stefan G Sarafianos
Journal:  PLoS Pathog       Date:  2013-01-22       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.